Valuation: Sartorius Stedim Biotech

Market Cap 18.07B 20.61B 16.7B 15.36B 28.98B 1,988B 29.45B 200B 78.28B 973B 77.4B 75.72B 3,351B P/E 2026 *
47.2x
P/E 2027 * 37.1x
Enterprise Value 20.08B 22.91B 18.56B 17.07B 32.21B 2,209B 32.73B 222B 87B 1,081B 86.03B 84.15B 3,724B EV / Sales 2026 *
6.34x
EV / Sales 2027 * 5.68x
Free-Float
28.47%
Yield 2026 *
0.46%
Yield 2027 * 0.55%
1 day-2.96%
1 week-4.81%
Current month-0.77%
1 month+11.30%
3 months-3.48%
6 months-12.69%
Current year-14.19%
1 week 179.9
Extreme 179.9
190.8
1 month 160.4
Extreme 160.4
190.8
Current year 150
Extreme 150
224
1 year 150
Extreme 150
224
3 years 139.1
Extreme 139.1
287.8
5 years 139.1
Extreme 139.1
551
10 years 50.13
Extreme 50.13
551
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Date Insider Type Main position Quantity % Market Cap.
12/17/25 SellCompany 750,000 0.7706%
2/16/24 Buy

Chief Executive Officer

1,716,739 1.8624%
3/2/22 SellCompany 200,442 0.2174%
Change 5-day change 1-year change 3-year change Capi.($)
-2.96%-4.81%-5.38%-24.13% 20.68B
+1.31%+10.75%-18.01%-8.78% 175B
+0.76%+0.29%-6.57%-6.20% 106B
-0.51%-0.04%+4.56%+58.22% 59.91B
+0.66%+0.96%+37.64%+54.22% 51.95B
-1.62%+1.49%-10.96%-40.73% 43.58B
-1.85%-3.83% - - 33.65B
-0.16%+0.01%-9.13%-41.55% 29.58B
-0.75%-1.11%+69.33%-6.08% 25.31B
-0.87%-0.68%-3.18%-6.33% 21.23B
Average -0.49%+1.56%+6.48%-2.37% 56.77B
Weighted average by Cap. +0.30%+2.70%-1.50%+0.59%

Financials

2026 *2027 *
Net sales 3.17B 3.61B 2.93B 2.69B 5.08B 348B 5.16B 34.98B 13.71B 170B 13.56B 13.26B 587B 3.5B 3.99B 3.23B 2.97B 5.61B 385B 5.7B 38.63B 15.14B 188B 14.97B 14.65B 648B
Net income 380M 434M 351M 323M 610M 41.82B 619M 4.2B 1.65B 20.46B 1.63B 1.59B 70.49B 475M 542M 439M 404M 762M 52.25B 774M 5.25B 2.06B 25.56B 2.03B 1.99B 88.08B
Net Debt 2.01B 2.3B 1.86B 1.71B 3.23B 221B 3.28B 22.24B 8.72B 108B 8.62B 8.43B 373B 1.77B 2.02B 1.63B 1.5B 2.84B 195B 2.88B 19.54B 7.66B 95.18B 7.57B 7.41B 328B
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,456
Date Price Change Volume
26-07-20 180.20 -2.96% 55,079
26-07-17 €185.70 -0.91% 107,069
26-07-16 €187.40 -0.85% 65,344
26-07-15 €189.00 +0.27% 52,185
26-07-14 €188.50 -0.42% 69,084
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
185.70EUR
Average target price
232.21EUR
Spread / Average Target
+25.05%

Quarterly revenue - Rate of surprise